Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1142683

registered interest
date	02/09/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Finance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans the Government has to support healthcare providers through winter 2019 in the event that the UK leaves the EU without a withdrawal agreement.
tabling member constituency	Stockton South
tabling member printed	Dr Paul Williams
uin	284153
answer	answer is ministerial correction date of answer 09/09/2019 answer text <p>The Department is working closely with NHS England and NHS Improvement to support National Health Service healthcare providers ahead of winter. This includes £240 million of funding that has been made available to help patients with adult social care needs leave hospital when ready and free-up hospital capacity.</p><p>As part of a responsible Government, the Department is doing everything appropriate to prepare for European Union exit. We want to reassure patients that our plans should ensure the supply of medicines and medical products remains uninterrupted when we leave the EU on 31 October.</p><p>The Department continues to monitor and analyse overall staffing levels in the NHS and we have been monitoring leaver and joiner rates of EU staff on a regular basis since the 2016 referendum. We are not complacent and have plans in place to ensure there will continue to be sufficient staff to deliver the high-quality services on which the public relies. Our overall programme of work is comprehensive, thorough and continuously updated and will stand irrespective of the terms in which the United Kingdom leaves the EU.</p><p>The Department is also working more broadly with delivery partners to ensure that the health and care system as a whole is prepared and ready to respond to disruption caused by EU exit.</p> answering member constituency Kingswood answering member printed Chris Skidmore question first answered 09/09/2019 19:07:24 answering member 4021 label Biography information for Chris Skidmore
tabling member	4666 label Biography information for Dr Paul Williams

1142686

registered interest
date	02/09/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Gene Therapies
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans NHS England has to implement gene therapy treatments.
tabling member constituency	Wolverhampton South West
tabling member printed	Eleanor Smith
uin	284172
answer	answer is ministerial correction date of answer 09/09/2019 answer text <p>As set out in the NHS Long Term Plan, the National Health Service is committed to supporting the timely introduction of the most clinically and cost effective treatments for patients. Cell and gene therapies have the potential to provide great benefits for patients, and the NHS is leading the world in creating access to these treatments.</p><p>For example, patients in England were among the first in the world to benefit from CAR T cell therapy, which uses their own immune system to fight cancers. The NHS will also now be funding voretigene neparvovec, also known as Luxturna, a revolutionary form of new treatment for blindness in children.</p><p>The NHS is working with the National Institute for Health and Care Excellence and other partners in the Accelerated Access Collaborative to take a proactive approach in preparing for cell and gene therapies and other innovative treatments.</p><p> </p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 09/09/2019 17:29:21 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4609 label Biography information for Eleanor Smith

1142687

registered interest
date	02/09/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cystic Fibrosis: Diagnosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the potential merits of making cystic fibrosis checks routine in (a) antenatal care and (b) neonatal care.
tabling member constituency	Bermondsey and Old Southwark
tabling member printed	Neil Coyle
uin	284174
answer	answer is ministerial correction date of answer 09/09/2019 answer text <p>The United Kingdom National Screening Committee (UK NSC) advises ministers and the National Health Service in the four UK countries about all aspects of screening and supports implementation of screening programmes. All screening programmes are introduced following a robust process using peer reviewed evidence that shows the benefits to screen clearly outweigh harm.</p><p>Earlier this year, the UK NSC looked at the evidence to offer population screening for cystic fibrosis (CF) in pregnancy and recommended that this should not be introduced. This is because screening during pregnancy would be difficult. Further, there is no new evidence to support screening. Ministers accepted this recommendation.</p><p>However, the NHS Newborn Blood spot Screening Programme screens for cystic fibrosis in newborn babies alongside eight other conditions. Newborn blood spot screening in England is offered between five and eight days after the baby is born.<em> </em></p><p><strong> </strong></p><p><strong><em> </em></strong></p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 09/09/2019 18:17:04 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4368 label Biography information for Neil Coyle

1142688

registered interest
date	02/09/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to make the stabilisation of conditions such as cystic fibrosis part of the NICE quality of life measurement system and not just extension of life.
tabling member constituency	Bermondsey and Old Southwark
tabling member printed	Neil Coyle
uin	284175
answer	answer is ministerial correction date of answer 09/09/2019 answer text <p>It has not proved possible to respond to the hon. Member in the time available before Prorogation.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 09/09/2019 17:27:04 answering member 4380 label Biography information for Jo Churchill
tabling member	4368 label Biography information for Neil Coyle

1142690

registered interest
date	02/09/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure the full NHS People Plan will tackle shortages in the imaging and diagnostic workforce in order to achieve the ambition in the NHS Long Term Plan to increase cancer screening uptake.
tabling member constituency	Burton
tabling member printed	Andrew Griffiths
uin	284178
answer	answer is ministerial correction date of answer 09/09/2019 answer text <p>It has not proved possible to respond to the hon. Member in the time available before Prorogation.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 09/09/2019 17:40:30 answering member 4380 label Biography information for Jo Churchill
tabling member	3936 label Biography information for Andrew Griffiths

1142692

registered interest
date	02/09/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 2 April 2019 to Question 236381, what steps NHS England has taken to fill the gap left by the closure of the Commissioning Support Programme for treatments that are awaiting review by the Clinical Priorities Advisory Group.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	284181
answer	answer is ministerial correction date of answer 09/09/2019 answer text <p>Further to the answer the Minister of State for Care (Caroline Dinenage MP) gave on 2 April 2019 to Question 236381, that NHS England has considered this issue, and does not believe that a gap has been created as a result of the closure of Commissioning Support Programme for treatments that are awaiting review by the Clinical Priorities Advisory Group.</p><p>The topics that would have been referred to the Commissioning Support Programme will now be routed to the appropriate appraisal programme.</p><p>All policy propositions relating to topics previously being supported in development through the Commissioning Support Programme have been handed over at the agreed stage for post stakeholder testing. These are now being progressed though the usual development process. Further information is available at the following link:</p><p><a href="https://www.england.nhs.uk/publication/methods-national-clinical-policies/" target="_blank">https://www.england.nhs.uk/publication/methods-national-clinical-policies/</a></p><p> </p><p> </p><p> </p> answering member constituency Kingswood answering member printed Chris Skidmore grouped question UIN 284182 question first answered 09/09/2019 18:52:46 answering member 4021 label Biography information for Chris Skidmore
tabling member	4131 label Biography information for Jim Shannon

1142693

registered interest
date	02/09/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential effect on treatments within NHS England’s Clinical Commissioning Policy programme of the closure of the Commissioning Support Programme; and if he will make a statement.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	284182
answer	answer is ministerial correction date of answer 09/09/2019 answer text <p>Further to the answer the Minister of State for Care (Caroline Dinenage MP) gave on 2 April 2019 to Question 236381, that NHS England has considered this issue, and does not believe that a gap has been created as a result of the closure of Commissioning Support Programme for treatments that are awaiting review by the Clinical Priorities Advisory Group.</p><p>The topics that would have been referred to the Commissioning Support Programme will now be routed to the appropriate appraisal programme.</p><p>All policy propositions relating to topics previously being supported in development through the Commissioning Support Programme have been handed over at the agreed stage for post stakeholder testing. These are now being progressed though the usual development process. Further information is available at the following link:</p><p><a href="https://www.england.nhs.uk/publication/methods-national-clinical-policies/" target="_blank">https://www.england.nhs.uk/publication/methods-national-clinical-policies/</a></p><p> </p><p> </p><p> </p> answering member constituency Kingswood answering member printed Chris Skidmore grouped question UIN 284181 question first answered 09/09/2019 18:52:46 answering member 4021 label Biography information for Chris Skidmore
tabling member	4131 label Biography information for Jim Shannon

1142733

registered interest
date	02/09/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Pensions
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what proportion of requests by NHS professionals to the NHS Business Services Authority to provide them with an accurate and up to date pension statement have been responded to in a timely manner in the most recent period for which figures are available.
tabling member constituency	Colne Valley
tabling member printed	Thelma Walker
uin	284282
answer	answer is ministerial correction date of answer 09/09/2019 answer text <p>The NHS Business Services Authority can provide ‘on demand’ Pension Savings Statements (PSS) to members on request. This is not triggered by a member breaching the annual allowance, but instead by the member requesting a statement. ‘On demand’ statements should be provided by the NHS Business Services Authority by the later of three months from the date of request by the individual or by 6 October following the end of the relevant tax year. However, this is dependent on the NHS Business Services Authority receiving the relevant data from the Employing Authority such as pensionable pay.</p><p>The NHS Business Services Authority cannot exclusively identify healthcare professionals but confirm that during the period of 1 April 2018 to 31 March 2019 it provided NHS Pension Scheme members with 17,187 ‘on demand’ PSSs of which 13,393 were completed on time.</p> answering member constituency Kingswood answering member printed Chris Skidmore question first answered 09/09/2019 18:38:13 answering member 4021 label Biography information for Chris Skidmore
tabling member	4649 label Biography information for Thelma Walker

1142736

registered interest
date	02/09/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Nusinersen
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the appropriateness of the NICE criteria for assessing a patient's access to Spinraza.
tabling member constituency	Wolverhampton South West
tabling member printed	Eleanor Smith
uin	284289
answer	answer is ministerial correction date of answer 09/09/2019 answer text <p>It has not proved possible to respond to the hon. Member in the time available before Prorogation.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 09/09/2019 17:25:25 answering member 4380 label Biography information for Jo Churchill
tabling member	4609 label Biography information for Eleanor Smith

1142749

registered interest
date	02/09/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the budget is for products undergoing review via the NHS England prioritisation process in 2020-21.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	284324
answer	answer is ministerial correction date of answer 09/09/2019 answer text <p>NHS England has not yet been set the budget for products undergoing review via the NHS England prioritisation process in 2020-21.</p> answering member constituency Kingswood answering member printed Chris Skidmore question first answered 09/09/2019 18:37:16 answering member 4021 label Biography information for Chris Skidmore
tabling member	4131 label Biography information for Jim Shannon